EXOZ
EXOZ
NASDAQ · Biotechnology

Exozymes Inc

$7.93
+0.42 (+5.59%)
As of Apr 1, 3:11 PM ET ·
Financial Highlights (FY 2025)
Revenue
13.14M
Net Income
-2,417,675
Gross Margin
59.8%
Profit Margin
-18.4%
Rev Growth
-4.0%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 59.8% 59.8% 59.8%
Operating Margin -18.6% -18.4% -19.0%
Profit Margin -18.4% -20.0% -21.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 13.14M 13.93M 11.00M
Gross Profit 7.86M 8.33M 6.58M
Operating Income -2,438,384 -2,563,817 -2,087,733
Net Income -2,417,675 -2,785,079 -2,350,186
Gross Margin 59.8% 59.8% 59.8%
Operating Margin -18.6% -18.4% -19.0%
Profit Margin -18.4% -20.0% -21.4%
Rev Growth -4.0% +11.1% -5.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 20.75M 17.80M 17.56M
Total Equity 48.48M 47.03M 51.63M
D/E Ratio 0.43 0.38 0.34
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,490,436 -4,206,535 -3,083,781
Free Cash Flow -1,263,655 -1,934,401 -1,577,892